Ana Isabel Ballesteros

Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

Isabel Echavarría, Sara López‐Tarruella, Antoni C. Picornell et al. · Clinical Cancer Research · 2018 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

Miguel Martín, Amparo Ruiz Simón, Manuel Ruíz Borrego et al. · Journal of Clinical Oncology · 2015 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series

Antoni C. Picornell, Isabel Echavarría, Enrique L. Álvarez et al. · BMC Genomics · 2019 · 60 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross‐sectional study

Concepción Pérez, Nike Sanchez-Martinez, Ana Isabel Ballesteros et al. · European Journal of Pain · 2014 · 50 citations · Full text

Medicine, Oncology, Cancer Screening +14

Primary lingual abscess presenting as acute swelling of the tongue obstructing the upper airway: diagnosis with MR.

Alberto Múñoz, Ana Isabel Ballesteros, J A Brandariz Castelo · PubMed · 1998 · 44 citations · Full text

Dentistry, Oral Radiology, Image Interpretation +12